Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate.

By J. Folkesson, H. Birgisson, L. Påhlman, B. Cedermark, B. Glimelius, U. Gunnarsson. Journal of Clinical Oncology, 2005

831 citations recorded by the source corpus.

Subfields: Oncology, Pulmonary and Respiratory Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/5f4f334213128ec862ce286ff04f211f68106bd5

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. K. Peeters
2. I. Nagtegaal
3. C. Marijnen
4. E. Kranenbarg
5. Hein Putter
6. T. Wiggers
7. C. J. van de Velde
8. J. Leer

Citations in the corpus

• The TME Trial After a Median Follow-up of 6 Years: Increased Local Control But No Survival Benefit in Irradiated Patients With Resectable Rectal Carcinoma (2007, background): “This contradicts data from the Swedish Rectal Cancer Trial that showed an effect of radiotherapy for this group of patients.(21) Also, the Swedish Rectal Cancer Register has demonstrated a significant effect on local recurrence rates by applying 5 5 Gy preoperatively for patients with low lying rect”